4.4 mg tirzepatide FDA approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly 249.00 | Tirzepatide --- 72

Caroline Messer, endocrinologist at Northwell Lenox Hill Hospital

The peptide is not approved by Health Canada for any therapeutic use, meaning licensed physicians cannot prescribe it and pharmacies cannot dispense it

In this guide, we compare Wegovy vs Ozempic to highlight the main differences and similarities between each treatment and help you understand which one may be the most appropriate option for you

And cost competitive

January 13, 2026: First Status Conference Held for Vision Loss Cases The first status conference for the Ozempic vision loss lawsuits grouped together in federal court has now been held

These insights help providers recommend continuous therapy and personalized dosing strategies, significantly reducing the likelihood of unintended weight regain